| Serial Number | 90690466 |
| Word Mark | EIKON THERAPEUTICS |
| Filing Date | Tuesday, May 4, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Thursday, September 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 2, 2022 |
| Description of Mark | The mark consists of an incomplete open circle which is partially bisected by four lines forming an open triangle and incomplete open triangle, where each of the four lines are connected by filled circles; the word "eikon" is immediately adjacent and over the word "therapeutics". |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 6, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EIKON THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Hayward, CA 94545 |
| Party Name | EIKON THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Hayward, CA 94545 |
| Event Date | Event Description |
| Friday, August 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 7, 2021 | NEW APPLICATION ENTERED |
| Monday, September 13, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, September 13, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, September 13, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 5, 2022 | ASSIGNED TO EXAMINER |
| Thursday, January 6, 2022 | NON-FINAL ACTION WRITTEN |
| Saturday, August 7, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, January 6, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, January 6, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, June 25, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, June 25, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, June 25, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, June 25, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, June 25, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 2, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 2, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, July 13, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 27, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, March 20, 2023 | SOU EXTENSION 1 FILED |
| Monday, March 20, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, March 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 22, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 5, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 22, 2023 | SOU EXTENSION 2 FILED |
| Friday, September 22, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, September 26, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 4, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, March 4, 2024 | SOU EXTENSION 3 FILED |
| Monday, March 4, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, September 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 5, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 5, 2024 | SOU EXTENSION 4 FILED |
| Thursday, September 5, 2024 | SOU EXTENSION 4 GRANTED |